Promise Bio
Promise Bio54About
What does Promise Bio do?
Promise Bio utilizes a cloud-based AI platform to perform unbiased, broad-range epiproteomic analyses on standard mass spectrometry data. Their technology focuses on studying post-translational modifications (PTMs) that regulate protein activity, offering deeper insights into biological processes.
What is Promise Bio's revenue?
StartupHub estimates Promise Bio's annual revenue at $2.5M (range $1.3M to $3.8M, 64% confidence), based on comparable companies in the sector.
What is Promise Bio's valuation?
StartupHub estimates Promise Bio's effective valuation at $40.0M (range $24.5M to $58.8M, 16% confidence), based on comparable companies in the sector.
How much funding has Promise Bio raised?
Promise Bio has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Promise Bio headquartered?
Promise Bio is headquartered in San Francisco, United States.
When was Promise Bio founded?
Promise Bio was founded in 2022.
What industry does Promise Bio operate in?
Promise Bio operates in Life Sciences, Biotech, Proteomics, HealthTech, Genomics, Drug Discovery.
How many employees does Promise Bio have?
Promise Bio has approximately 14 people on record.
What is Promise Bio's current status?
Promise Bio's current operating status is: Inactive.
No comments yet. Be the first to share your take.